STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. announced today the presentation of results from six clinical and non-clinical research studies at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting 2017 in Denver, Mar. 27-30, 2017.
“Epidemiology of Opioid Use in a State Medicaid Program”
The selected posters include:
| Poster # | TITLE | AUTHORS | ||
| U14 | Wearable Health Technologies to Treat Chronic Pain: Establishing Baseline Treatment Effects in a Multidisciplinary Pain Program | Graham J, Alfieri T, Baylor K, Robishaw S, Bond C, Mayne T, Han J | ||
| U18 | Epidemiology of Opioid Use in a NC State Medicaid Program | Pham TT, Skrepnek GH, Bond C, Alfieri T, Cothran TJ, Keast SL | ||
| U19 | Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Costs in Commercial and Medicare Plans | Howard J, Chen C, De AP, Wade RL | ||
| U20 | Assessing the Impact of a Community-based Overdose Prevention in Rural North Carolina | Brason F, Alfieri T, Mayne T | ||
| U26 | Prescription Opioid Deaths in a NC State Medicaid Population, 2012-2014 | Pham TT, Skrepnek GH, Bond C, Alfieri T, Cothran TJ, Keast SL | ||
| U36 | Understanding Factors that Contribute to Opioid Misuse and Diversion | Bond TC, Howard JC, Mayne T |
“We are pleased to present results from several studies that show our commitment to the pain community while addressing the opioid crisis and encouraging responsible prescribing, storage and disposal,” said Gail Cawkwell, M.D., Ph.D., Vice President, Chief Medical Officer, Purdue Pharma L.P. “Through continued research, we aim to improve care for millions of patients suffering from chronic pain in the U.S. and are committed to continuously improving the future design of disposal and take-back programs that aim to improve public health outcomes by reducing the amount of medicine available for misuse and diversion.”
